Literature DB >> 20364043

Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.

Gang Wang1, Bonnie Ching-Ha Kwan, Fernand Mac-Moune Lai, Kai-Ming Chow, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

BACKGROUND: Micro-RNAs (miRNAs) regulate one-third of all protein-coding genes and are fundamental in the pathophysiology of a wide range of diseases. We studied the expression of several miRNA species (miR-200 family, miR-205 and miR-192) in the urinary sediment of patients with IgA nephropathy (IgAN).
METHODS: We studied 43 patients with biopsy-proven IgAN. Urinary expression of miRNAs was determined and compared to that from 13 healthy controls.
RESULTS: The levels of urinary miR-200a, miR-200b and miR-429, but not miR-200c, miR-141, miR-205, or miR-192, were down-regulated in patients with IgAN. Proteinuria significantly correlated with urinary expression of miR-200a (r= -0.483, P < 0.001), miR-200b (r= -0.448, P=0.001) and miR-429 (r=-0.466, P=0.001). Baseline renal function significantly correlated with urinary expression of miR-200b (r= 0.512, P < 0.001) and miR-429 (r=0.425, P=0.005). Urinary gene expression of ZEB2 inversely correlated with miR-200b (r=-0.321, P=0.017); and vimentin expression inversely correlated with that of miR-200a (r=-0.360, P=0.007), miR-200b (r=-0.416, $P =$ 0.002) and miR-429 (r=-0.375, P=0.005). After 33.4 +/- 12.6 months, the rate of renal function decline significantly correlated with urinary expression of miR-200b (r=0.316, P=0.034).
CONCLUSIONS: Urinary expression of miR-200a, miR-200b and miR-429 were down-regulated in patients with IgAN, and the degree of reduction correlated with disease severity and rate of progression. The results suggested that these miRNA species might play important roles in the pathophysiology of IgAN. Further studies are needed to clarify the role of urinary miRNA repression as a non-invasive marker of IgAN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364043      PMCID: PMC3833417          DOI: 10.3233/DMA-2010-0687

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  52 in total

Review 1.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

2.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

3.  Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.

Authors:  Jian Teng; Fang Sun; Peng-Fei Yu; Ji-Xia Li; Dong Yuan; Jing Chang; Shu-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Authors:  Janina Müller-Deile; Jan Dannenberg; Patricia Schroder; Meei-Hua Lin; Jeffrey H Miner; Rongjun Chen; Jan-Hinrich Bräsen; Thomas Thum; Jenny Nyström; Lynne Beverly Staggs; Hermann Haller; Jan Fiedler; Johan M Lorenzen; Mario Schiffer
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

Review 5.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

6.  Reduced mir-29b-3p expression up-regulate CDK6 and contributes to IgA nephropathy.

Authors:  Li-Na Xing; Hao Wang; Pei-Hao Yin; Yu-Jun Liu; Yang-Feng Chi; Yun-Man Wang; Wen Peng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 7.  The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer.

Authors:  Isamu Hoshino
Journal:  Int J Clin Oncol       Date:  2021-04-09       Impact factor: 3.402

Review 8.  MicroRNAs and the glomerulus.

Authors:  Mitsuo Kato; Jung Tak Park; Rama Natarajan
Journal:  Exp Cell Res       Date:  2012-03-05       Impact factor: 3.905

Review 9.  Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.

Authors:  Johanna K DiStefano; Matthew Taila; M Lucrecia Alvarez
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 10.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.